Featured Research

from universities, journals, and other organizations

Molecular System Involved In Blood Clotting May Play A Role In Alzheimer's Disease

Date:
June 7, 2000
Source:
University Of Kentucky Medical Center
Summary:
The molecular system that regulates blood clotting, called the plasmin system, also may be involved in the development of Alzheimer's disease, according to a study led by researchers at the University of Kentucky Chandler Medical Center and published in the June 1 issue of The Journal of Neuroscience.

The molecular system that regulates blood clotting, called the plasmin system, also may be involved in the development of Alzheimer's disease, according to a study led by researchers at the University of Kentucky Chandler Medical Center and published in the June 1 issue of The Journal of Neuroscience.

Because of its role in Alzheimer's disease, the molecules involved in the plasmin system may lead to treatments for Alzheimer's disease. The study was led by Steven Estus, Ph.D., assistant professor, and H. Michael Tucker, Ph.D., researcher, both in the Department of Physiology at the UK College of Medicine and the UK Sanders-Brown Center on Aging.

About 60,000 Kentuckians have Alzheimer's disease, and, nationally, 4 million people are estimated to have the disease. A protein called amyloid-beta is thought to be critical in the development of Alzheimer's disease, although the exact role of amyloid-beta is unknown. Aggregated amyloid-beta proteins, also called amyloid fibrils, are found in the brains of Alzheimer's patients.

Blood clots routinely form in blood vessels. It is crucial that these clots be destroyed before they cause heart attacks or strokes. This destruction is accomplished by activating the plasmin system. The plasmin system regulates the process of blood clotting and also plays a role in cell migration. The principal molecules involved in regulating blood clots are plasminogen/plasmin, tissue plasminogen activator (tPA), urokinase-type plasminogen activator (uPA), plasminogen activator inhibitor (PAI-1), and alpha-2-antiplasmin (a2-AP). The U.S. Food and Drug Administration has approved synthetic tPA for use in treating heart attacks or strokes within a few hours of the onset of symptoms. The drug dissolves the blood clot that is causing the heart attack or stroke.

The first step in destroying blood clots is the production of the proteins tPA and uPA in tissues near the blood clot. These two proteins cut the molecule plasminogen to form plasmin. Plasmin then destroys the target protein. In the case of blood clots, the target is a protein called fibrin. PAI-1 and a2-AP work to control the process by inhibiting the activity of tPA and uPA.

"The tPA protein also binds to clumps of amyloid-beta protein. So what we needed to explore was whether plasmin destroys amyloid-beta as it does fibrin and whether plasmin exhibits any neurotoxic effects," Estus said.

The results showed that aggregated amyloid-beta stimulates the production of both tPA and uPA, that plasmin destroys non-aggregated and aggregated amyloid-beta proteins as well as it destroys fibrin, and that plasmin appears to have no direct toxic effects in the brain.

Also, previous research has shown that the amount of the protein PAI-1, which inhibits the activity of tPA, is increased in Alzheimer's disease and inflammation, a common symptom of Alzheimer's.

"With these results and previous research, we can suggest a model of the development of Alzheimer's disease. Specifically, inflammation increases the amount of tPA inhibitors, which prevents the destruction of amyloid-beta proteins by obstructing the action of tPA. The increased levels of amyloid-beta cause further inflammation that feeds the cycle again," Tucker said.

"The particularly exciting thing about these results is that they suggest that it may be possible to treat Alzheimer's disease by destroying amyloid-beta protein deposits with tPA that is modified to target brain tissue," Estus said.

Further research will explore the accuracy of this model and whether tPA can be modified effectively to target brain tissue.

The study was funded by American Health Assistance Foundation, a private foundation that supports Alzheimer's disease research


Story Source:

The above story is based on materials provided by University Of Kentucky Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Kentucky Medical Center. "Molecular System Involved In Blood Clotting May Play A Role In Alzheimer's Disease." ScienceDaily. ScienceDaily, 7 June 2000. <www.sciencedaily.com/releases/2000/06/000602074152.htm>.
University Of Kentucky Medical Center. (2000, June 7). Molecular System Involved In Blood Clotting May Play A Role In Alzheimer's Disease. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2000/06/000602074152.htm
University Of Kentucky Medical Center. "Molecular System Involved In Blood Clotting May Play A Role In Alzheimer's Disease." ScienceDaily. www.sciencedaily.com/releases/2000/06/000602074152.htm (accessed October 21, 2014).

Share This



More Mind & Brain News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Your Birth Season Might Determine Your Temperament

Your Birth Season Might Determine Your Temperament

Newsy (Oct. 20, 2014) A new study says the season you're born in can determine your temperament — and one season has a surprising outcome. Video provided by Newsy
Powered by NewsLook.com
Court Ruling Means Kids' Online Activity Could Be On Parents

Court Ruling Means Kids' Online Activity Could Be On Parents

Newsy (Oct. 17, 2014) In a ruling attorneys for both sides agreed was a first of its kind, a Georgia appeals court said parents can be held liable for what kids put online. Video provided by Newsy
Powered by NewsLook.com
The Best Foods To Boost Your Mood

The Best Foods To Boost Your Mood

Buzz60 (Oct. 17, 2014) Feeling down? Reach for the refrigerator, not the medicine cabinet! TC Newman (@PurpleTCNewman) shares some of the best foods to boost your mood. Video provided by Buzz60
Powered by NewsLook.com
You Can Get Addicted To Google Glass, Apparently

You Can Get Addicted To Google Glass, Apparently

Newsy (Oct. 15, 2014) Researchers claim they’ve diagnosed the first example of the disorder in a 31-year-old U.S. Navy serviceman. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins